PA
PRCT icon

Pineridge Advisors’s Procept Biorobotics PRCT Stock Holding History

Pineridge Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18
Closed -$1.44K – 629
2024
Q4 		$1.44K Buy
18
+17
+1,700% +$1.45K ﹤0.01% 509
2024
Q3 		$80 Sell
1
-9
-90% -$639 ﹤0.01% 580
2024
Q2 		$611 Buy
+10
New +$595 ﹤0.01% 562

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pineridge Advisors's PRCT Position: Q1 2025 in Review

Pineridge Advisors sold out of Procept Biorobotics (PRCT) in Q1 2025, closing a stake of 18 shares — an estimated $1.44K sold.

Pineridge Advisors first reported a position in PRCT in Q2 2024 and held it in 3 quarters. The position peaked at $1.44K in Q4 2024. 279 funds tracked by Wall St. Rank hold PRCT as of Q1 2025.

  • Pineridge Advisors reported no remaining Procept Biorobotics position as of Q1 2025 after selling out during the quarter.
  • Pineridge Advisors sold 18 Procept Biorobotics shares in Q1 2025, an estimated $1.44K.
  • Pineridge Advisors first reported a position in Procept Biorobotics in Q2 2024 and held it in 3 quarters.
  • Pineridge Advisors's Procept Biorobotics position peaked at $1.44K in Q4 2024.
  • 279 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2025.

Based on Pineridge Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.